Monocyte chemoattractant protein‐1 in the aqueous humour of patients with age‐related macular degeneration
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: To investigate the role of inflammation in age‐related macular degeneration by measuring the levels of cytokines in the aqueous humour. Methods: Samples of aqueous humour were collected from 34 patients with age‐related macular degeneration and 16 age‐matched control subjects undergoing cataract surgery. Age‐related macular degeneration stage was determined clinically, before surgery. Levels of cytokines were measured using Luminex X‐MAP technology, and positive results were verified by Western blot. Results: Age‐related macular degeneration was moderate in 18 patients and advanced in 16. The advanced age‐related macular degeneration group was further divided into patients with active choroidal neovascularization (n = 7), disciform scar (n = 7) or central geographic atrophy (n = 2). Higher‐than‐normal levels of monocyte chemoattractant protein‐1 in the aqueous humour were associated with advanced age‐related macular degeneration (200 ± 140 pg/mL vs. 100 ± 61 pg/mL; P = 0.03), especially active choroidal neovascularization (255 ± 155 pg/mL; P = 0.02), Western blot analysis verified the monocyte chemoattractant protein‐1 findings. Patients with disciform scar showed a trend of abnormally high levels of interleukin‐12 (p70) (1.7 ± 2.4 pg/mL vs. 0.2 ± 1 pg/mL; P = 0.07), tumour necrosis factor‐α (1.8 ± 2.4 pg/mL vs. 0.3 ± 1 pg/mL; P = 0.06) and interleukin‐12 (4.7 ± 6.4 pg/mL vs. 1.2 ± 2.1 pg/mL; P = 0.08). Conclusion: Elevated levels of inflammation‐related cytokines in the aqueous humour in various stages of age‐related macular degeneration may suggest a pathogenic role of inflammation. Monocyte chemoattractant protein‐1 may be indicative of the angiogenic phase. Further corroborative studies are required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice
Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J., & Ambati, B. K. (2003) · Nature Medicine · doi:10.1038/nm950 · Cited by 631
Gupta, N., Brown, K. E., & Milam, A. H. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00332-9 · Cited by 582
Immunological and Aetiological Aspects of Macular Degeneration
Penfold, P. L., Madigan, M. C., Gillies, M. C., & Provis, J. M. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(00)00025-2 · Cited by 460 · cited 1×
“It has also been reported that the expression of MCP-1 was upregulated in cultured RPE cells in response to various stimuli, including other cytokines;(7) and that MCP-1 was found in surgically excised CNV samples from patients.(12) Noda et al.”
BackgroundSenescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice
Kelly, J., Khan, A. A., Yin, J., Ferguson, T. A., & Apte, R. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32430 · Cited by 249
Control of chemokine production at the blood-retina barrier
Crane, I. J., Wallace, C. A., Mckillop‐Smith, S., & Forrester, J. V. (2000) · Immunology · doi:10.1046/j.0019-2805.2000.01105.x · Cited by 77 · cited 5×
“Our findings are supported by the recent study of Jonas et al., which found that MCP-1 levels were elevated in patients with CNV, and were correlated with the type of CNV.16 Collectively, the presence of MCP-1 in control samples, its stable levels in the patients with moderate disease in our study, its elevated levels…”
BackgroundInfluentialRoss, R. J., Zhou, M., Shen, D., Fariss, R. N., Ding, X., Bojanowski, C. M., Tuo, J., & Chan, C.-C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.014 · Cited by 60
Cited by
The Role of Inflammation in Age-Related Macular Degeneration
Tan, W., Zou, J., Yoshida, S., Jiang, B., & Zhou, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.49890 · Cited by 311
Cheng, S.-C., Huang, W.-C., S. Pang, J.-H., Wu, Y.-H., & Cheng, C.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122957 · Cited by 235
“MCP-1 (also called CCL2) belongs to the C–C chemokine family and stimulates and attracts monocytes and lymphocytes, resulting in monocyte/macrophage infiltration [80,81].”
BackgroundOn phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
Metadata
- Authors
- Kramer, M., Hasanreisoglu, M., Feldman, A., Axer‐Siegel, R., Sonis, P., Maharshak, I., Monselise, Y., Gurevich, M., & Weinberger, D.
- Venue
- Clinical & Experimental Ophthalmology
- Publisher
- Wiley
- Published
- 2012-02-20
- Volume
- 40
- Issue
- 6
- Pages
- 617-625
- ISSN
- 1442-6404 (ISSN-L)
- 1442-9071
- OpenAlex
- W1510587544
- Cited by
- 50
- References
- 6
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monocyte chemoattractant protein‐1 in the aqueous humour of patients with age‐related macular degeneration. https://app.cochat.ai/papers/10.1111/j.1442-9071.2011.02747.x
- The paper
- Kramer, M., Hasanreisoglu, M., Feldman, A., Axer‐Siegel, R., Sonis, P., Maharshak, I., Monselise, Y., Gurevich, M., & Weinberger, D. (2012). Monocyte chemoattractant protein‐1 in the aqueous humour of patients with age‐related macular degeneration. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/j.1442-9071.2011.02747.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.